MabThera

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. As the world's largest biotech company, Roche develops differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and neuroscience. The company is the developer and manufacturer of MabThera (rituximab), a foundational monoclonal antibody therapy for B-cell malignancies and autoimmune disorders. Roche's unique strategy combines excellence in both pharmaceuticals and diagnostics to deliver personalized healthcare solutions. With a history dating back to 1896, the company has produced numerous essential medicines on the WHO Model List of Essential Medicines. Roche continues to invest heavily in research and development to address unmet medical needs across a broad range of therapeutic areas.